KIT and acute myeloid leukemia: Here we describe the case of a 31-year-old female with AML harboring t(8;21) and a KIT D816H mutation that relapsed following allogeneic hematopoietic stem cell transplant (alloHSCT) and was successfully treated with avapritinib monotherapy.